Insulin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis
Condition: DKA Intervention: Drug: Insulin Glargine Sponsor: HealthPartners Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes
Conditions: Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients; Metformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect; 128 Patients Were Randomly Assigned 1:1; Metformin and Insulin Glargine Combin ed With Chiglitazar Sodium Tablets 48mg/ Day Group; Metformin and Insulin Glargine Combined With Placebo Group; InvestigatorInitiate Trial; Changes in HbA1C From Baseline at 18 Weeks of Treatment Interventions: Drug: Chiglitazar sodium; Drug: Chiglitazar placebo Sponsor: Yanbing Li Not yet rec...
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials

Comparison Of Outcome Of Microneedling With Autologous PRP Vs Microneedling With Topical Insulin In Treatment Of Post Acne Atrophic Scars.
Condition: ATROPHIC ACNE SCARS Intervention: Drug: PRP( platelet rich plasma) and Insulin human Sponsor: Jinnah Postgraduate Medical Centre Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2023 Category: Research Source Type: clinical trials

Intranasal Insulin for Treatment of Alcohol Use Disorder
Condition: Alcohol Use Disorder Interventions: Drug: Regular Human Insulin then Placebo; Drug: Placebo then Regular Human Insulin Sponsor: Brown University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials